You already track HRV, glucose, and sleep latency. But the number that actually predicts how the next thirty years go isn't on your driver's license — and it isn't a single score from a saliva kit either.
Why "biological age" is a useful frame, not a finish line
Chronological age is a clock that only moves one way. Biological age is an attempt to estimate how worn the underlying systems are — and people of the same chronological age can differ substantially in measured molecular and physiological markers [1]. That gap is the interesting part. The problem is that "biological age" has been packaged into single-number consumer scores that imply more precision than the underlying science supports.
A more honest model: aging is a set of interacting processes — genomic and epigenetic change, chronic low-grade inflammation, and metabolic dysregulation among them [1]. No one biomarker captures all of it. A physician's job isn't to chase a single score; it's to read several markers as a panel, against your history and your self-tracked data, and notice where they disagree. Disagreement is signal.
This article is educational and is not medical advice. Which labs are appropriate for you, and how to interpret them, is a decision for an independent licensed provider.
Epigenetic clocks: the marker everyone quotes, with the most caveats
Epigenetic clocks estimate age from DNA methylation — chemical tags on DNA that shift in patterned ways over the lifespan. The first-generation Horvath clock estimated chronological age across many tissue types with a median error of a few years [2]. Later "second-generation" clocks (PhenoAge, GrimAge) were trained against clinical and mortality-related outcomes rather than calendar age, which is why they correlate more strongly with health-related endpoints in research cohorts [3].
Here's the engineer's caveat: these clocks are powerful research tools, but consumer epigenetic-age tests can show meaningful test-retest variability, and methylation can be influenced by which cells were in the sample. Treat a single epigenetic-age readout as one noisy data point — useful in trend, weak in isolation. That's precisely why a clinician reads it alongside blood-based markers rather than in place of them.
mg/L · marker = Upper average cutoff
Source: [6] Pearson et al., AHA/CDC Markers of Inflammation and Cardiovascular Disease (Circulation)
Fasting insulin and metabolic aging
Fasting glucose is the marker most people watch; fasting insulin is often the earlier one. The body can keep glucose in range for years by quietly producing more insulin — so a "normal" glucose can sit on top of rising insulin resistance. HOMA-IR, calculated from fasting glucose and fasting insulin, is a widely used research estimate of insulin resistance [4].
For someone already running a CGM, this is the natural bridge: your continuous glucose curves describe day-to-day response, while fasting insulin and HOMA-IR add the longer-arc question of how hard your pancreas is working to produce those curves. The American Diabetes Association's diagnostic thresholds for glucose and HbA1c are the reference frame a provider starts from [5].
hs-CRP: the inflammation dial
High-sensitivity C-reactive protein (hs-CRP) is a blood marker of systemic inflammation. The American Heart Association and CDC described risk strata for cardiovascular risk assessment: low risk under 1.0 mg/L, average 1.0–3.0 mg/L, and higher above 3.0 mg/L [6]. Chronic low-grade inflammation — sometimes called "inflammaging" — is one of the recognized hallmarks of aging and overlaps with metabolic and cardiovascular risk [1].
hs-CRP is sensitive but non-specific: a recent cold, hard training block, or injury can transiently raise it. That's why a single elevated value isn't a diagnosis — it's a prompt to repeat and interpret in context, which is exactly the kind of nuance self-collected data alone can't supply.
Source: [2] Horvath S., DNA methylation age of human tissues and cell types (Genome Biology), [4] Matthews et al., Homeostasis model assessment (HOMA) (Diabetologia), [6] Pearson et al., AHA/CDC Markers of Inflammation and Cardiovascular Disease (Circulation)
Lipid-based "metabolic age" and the limits of composite scores
Many consumer reports fold lipids — total cholesterol, HDL, triglycerides — into a single "metabolic age." The individual inputs are real and meaningful; the standard lipid panel and its risk interpretation are well established in cardiology guidelines [7]. But the composite "age" number layered on top is a derived index, and different vendors compute it differently. The underlying lipids belong in your panel. The marketing number on top is the part to hold loosely.
Reading the panel together — the part a score can't do
The value isn't any single biomarker; it's the pattern. A normal glucose with rising fasting insulin, a flattering epigenetic score sitting next to an hs-CRP of 4 mg/L, good lipids with poor recovery data — these are the contradictions that a clinician resolves by looking at everything at once, including your HRV and sleep exports. A panel read longitudinally, by the same provider, against your own goals, is worth far more than a prettier one-number dashboard.
This is also where peptide and recovery interest meets reality: the responsible sequence is measure, interpret with a licensed provider, then decide — not source-first and guess. Any prescription decision rests entirely with an independent licensed provider, and is never guaranteed. Some longevity-adjacent products discussed in this space are compounded. Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Source: [1] López-Otín et al., Hallmarks of Aging: An Expanding Universe (Cell)
A sane way to think about your own data
- Trend over snapshot. One epigenetic readout or one hs-CRP is noise; the slope over repeated measures is signal.
- Confirm before acting. Sensitive markers (hs-CRP, insulin) deserve a repeat before any conclusion.
- Keep composites in their place. Use the underlying biomarkers; treat single "bio age" numbers as a conversation-starter.
- Bring your wearable data to the table. CGM, HRV, and sleep aren't replacements for labs — together with labs, they let a provider see context a snapshot misses.
Where Velri fits
Velri is a technology and coordination company — not a medical practice. Velri can help coordinate diagnostic lab work and connect you with an independent, licensed provider group who reviews your results, considers the biomarkers above as a panel (and the self-tracked data you bring), and decides what, if anything, is clinically appropriate. If a provider determines a prescription is appropriate, it can be filled through an independent licensed pharmacy. Velri does not provide medical care, does not guarantee any prescription, and the content here is educational, not medical advice. Your data is handled with discretion, and clinical decisions remain entirely with your independent provider.
